Antimetastatic effects of chamuangone-enriched extract in breast cancer lung metastasis: in vitro and in vivo evidence
Medical Oncology · 2025
DOI: 10.1007/s12032-025-03076-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Asad Ur Rahman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, 90112, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Lung Neoplasms, Plant Extracts, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 42 Literaturangaben. Gefördert von: PSU Reinventing University Grant, Wuxi Municipal Health commission Youth Project, Top Talent Support Program for Youth and Middle-aged People of Wuxi Health Committee.
Abstract (Originalsprache)
Breast cancer lung metastasis (BCLM) is the most lethal form of breast cancer (BC). Current treatments are costly and often associated with severe side effects, emphasizing the need for alternative therapies. A chamuangone-enriched extract (CEE), quantitatively standardized by HPLC to contain 73.0 ± 2.0% w/w chamuangone, was developed from the leaves of the Thai vegetable Garcinia cowa and evaluated for its anticancer efficacy. Both in vitro and in vivo studies were conducted using MCF-7 cells in a human breast cancer xenograft model. Histopathological examination of the tumor and lungs, as well as expression of BCLM markers (ER, PR, Ki-67, CD44, IL-6, TNF-α, VEGFA, E-cadherin, and N-cadherin) expression in the tumor and lungs were evaluated through immunohistochemistry. In vitro studies, CEE at a concentration of 10 µg/mL inhibited MCF-7 cell growth and migration, induced apoptosis, and significantly modulated apoptotic and inflammatory markers (p53 and Bcl-2, MMP-2, MMP-9, IL-6, and TNF-α) in MCF-7 cells. In vivo studies, CEE (100 mg/kg bodyweight) significantly inhibited tumor growth and decreased the expressions of BCLM markers in tumor and lung tissues, resulting in the suppression of BC and metastasis. These results support the potential medicinal and protective use of CEE as a functional ingredient for mitigating the devastating effects of BC and BCLM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, 90112, Thailand.
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310013, China. naveedkhan1676@hotmail.com.
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, 214000, People's Republic of China.
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, 90112, Thailand. pharkphoom.p@psu.ac.th.
- Phytomedicine and Pharmaceutical Biotechnology Excellence Centre, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, 90112, Thailand. pharkphoom.p@psu.ac.th.
Förderung
- PSU Reinventing University Grant
- Wuxi Municipal Health commission Youth Project
- Top Talent Support Program for Youth and Middle-aged People of Wuxi Health Committee
Zitieren
APA
Rahman, A. U., Khan, N. U., Ni, J., & Panichayupakaranant, P. (2025). Antimetastatic effects of chamuangone-enriched extract in breast cancer lung metastasis: in vitro and in vivo evidence. Medical Oncology. https://doi.org/10.1007/s12032-025-03076-7
Vancouver
Rahman AU, Khan NU, Ni J, Panichayupakaranant P. Antimetastatic effects of chamuangone-enriched extract in breast cancer lung metastasis: in vitro and in vivo evidence. Medical Oncology. 2025. doi:10.1007/s12032-025-03076-7
BibTeX
@article{Rahman2025,
author = {Rahman, Asad Ur and Khan, Naveed Ullah and Ni, Jiang and Panichayupakaranant, Pharkphoom},
title = {Antimetastatic effects of chamuangone-enriched extract in breast cancer lung metastasis: in vitro and in vivo evidence},
journal = {Medical Oncology},
year = {2025},
doi = {10.1007/s12032-025-03076-7}
}
EUVIMED